Submission to the review of the Tasmanian Opioid Pharmacotherapy Program

The ATDC supports the provision of pharmacotherapy as a key harm reduction intervention that seeks to reduce drug related harm in the Tasmanian community.

This submission advances the perspective of Tasmanian Opioid Pharmacotherapy Program (TOPP) service user as well as encompasses the practice wisdom of those who work with people with ATOD issues in the community sector in Tasmania. We are providing feedback on how the TOPP system works as well as how the TOPP service user fares within that system.

Out of scope for this submission is a detailed look at clinical guidelines, apart from those that necessarily include psycho social supports, ethical issues as well as information on how to work with the system. We understand the
risk to consumers from opioids but we also understand the risk to consumers if a model of service is not responsive to their health needs.